Ocular Therapeutix, Inc. - Common Stock (NQ:OCUL)

7.300 +0.100 (+1.39%)

Delayed Quote Updated: 2:57 PM EDT, Oct 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ocular Therapeutix, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

June 20, 2024

Via Benzinga

KB Home Reports Upbeat Earnings, Joins Harrow, Accenture, Gilead Sciences And Other Big Stocks Moving Higher On Thursday ↗

June 20, 2024

Via Benzinga

Deep Dive Into Ocular Therapeutix Stock: Analyst Perspectives (6 Ratings) ↗

June 14, 2024

Via Benzinga

The Analyst Verdict: Ocular Therapeutix In The Eyes Of 8 Experts ↗

April 16, 2024

Via Benzinga

Decoding 6 Analyst Evaluations For Ocular Therapeutix ↗

March 13, 2024

Via Benzinga

This Skyworks Solutions Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday ↗

June 20, 2024

Via Benzinga

Workday To Rally Over 52%? Here Are 10 Top Analyst Forecasts For Thursday ↗

June 20, 2024

Via Benzinga

Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

June 14, 2024

Via Benzinga

Ocular Therapeutix: Q4 Earnings Insights ↗

March 11, 2024

Via Benzinga

Earnings Outlook For Ocular Therapeutix ↗

March 08, 2024

Via Benzinga

Hasbro, Tutor Perini, Arm Holdings And Other Big Stocks Moving Higher On Friday ↗

June 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 28, 2024

Via Benzinga

OCUL Stock Earnings: Ocular Therapeutix Misses EPS, Misses Revenue for Q1 2024 ↗

May 07, 2024

OCUL stock results show that Ocular Therapeutix missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

May 06, 2024

Via Benzinga

BioNTech Reports Downbeat Earnings, Joins Medical Properties Trust And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

May 06, 2024

Via Benzinga

2 Small-Cap Growth Stocks With Room To Run ↗

April 24, 2024

These two small-cap growth stocks could be ready to run.

Via The Motley Fool

Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 19, 2024

Via Benzinga

Ocular Therapeutix Highlights Early Data From Diabetes-Related Eye Disorder ↗

April 18, 2024

Ocular Therapeutix's Phase 1 HELIOS study unveils Axpaxli's efficacy in treating non-proliferative diabetic retinopathy. Significant DRSS improvement with no worsening observed. Positive Phase 2 data...

Via Benzinga

Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

April 18, 2024

Via Benzinga

The 3 Best Biotech Stocks to Buy Now: Q2 Edition ↗

April 16, 2024

Investors can find some of the hottest, most explosive opportunities in these three top biotech stocks to buy now.

Via InvestorPlace

Biotech on a Budget: 7 Stocks Under $10 With Huge Potential ↗

April 15, 2024

With the medical care industry always liable for negative surprises, you might as well go for big upside with under-$10 biotech stocks.

Via InvestorPlace

Million-Dollar Bets: 3 Under-$15 Stocks With Massive Potential ↗

April 01, 2024

Here are three under-$15 stocks with massive potential based on their strategic moves in the pharmaceuticals and banking industries.

Via InvestorPlace

These Analysts Boost Their Forecasts On Ocular Therapeutix After Q4 Results ↗

March 12, 2024

Ocular Therapeutix, Inc. (NASDAQ: OCUL) reported worse-than-expected fourth-quarter financial results on Monday.

Via Benzinga

Why Oracle Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗

March 12, 2024

Shares of Oracle Corporation (NYSE: ORCL) rose sharply in today’s pre-market trading after the company reported upbeat earnings for its fis

Via Benzinga

Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 12, 2024

Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.

Via Benzinga

ACADIA Pharmaceuticals, Ocular Therapeutix, Asana And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

March 12, 2024

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 50 points on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 11, 2024

Via Benzinga

Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket ↗

March 11, 2024

Shares of Fangdd Network Group Ltd. (NASDAQ: DUO) rose sharply in today’s pre-market trading after the company announced its 2024 strategic layout with plans to enter the real estate stock asset...

Via Benzinga

Earnings Scheduled For March 11, 2024 ↗

March 11, 2024

Companies Reporting Before The Bell • Ballard Power Systems (NASDAQ:BLDP) is estimated to report quarterly loss at $0.13 per share on revenue of $34.20 million.

Via Benzinga

$7M Bet On Ocular Therapeutix? Check Out These 3 Stocks Insiders Are Buying ↗

February 28, 2024

Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.